Importance During the COVID-19 pandemic, urgent clinical management of patients has
mainly included drugs currently administered for other diseases, referred to as repositioned …

Purpose The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus has affected millions all over the world and has …

Background Polypharmacy has traditionally been defined in various texts as the use of 5 or
more chronic drugs, the use of inappropriate drugs, or drugs that are not clinically …

Drug–drug interactions (DDIs) are a major concern in clinical practice and have been
recognized as one of the key threats to public health. To address such a critical threat, many …

1. Background Recent years, particularly the COVID-19 pandemic, can be considered a
turning point for pharmacovigilance and pharmacoepidemiology in terms of their role in drug …

The modulation of the pharmacological action of drugs due to drug-drug interactions (DDIs)
is a critical issue in healthcare. The aim of this study was to evaluate the prevalence and the …

Introduction The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario
in which the use of psychotropic drugs may be required. This requires the support of …

Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems
worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to …

ABSTRACT Introduction The coronavirus (COVID-19) pandemic has led to as well as
exacerbated mental health disorders, leading to increased use of psychotropic medications …

Resumen OTERINO-MOREIRA, I et al. Incidence of adverse drug reactions in COVID-19
hospitalised patients through the minimum basic data setIncidencia de reacciones adversas …